Skip to main content
Veterinary Medicines

KALIPROFEN LA 50 mg/ml raztopina za injiciranje za govedo

Authorised
  • Carprofen

Product identification

Medicine name:
KALIPROFEN LA 50 mg/ml raztopina za injiciranje za govedo
Active substance:
  • Carprofen
Target species:
  • Cattle
Route of administration:
  • Subcutaneous use
  • Intravenous use

Product details

Active substance and strength:
  • Carprofen
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Meat and offal
        21
        day
      • Milk
        0
        hour
  • Intravenous use
    • Cattle
      • Milk
        0
        hour
      • Meat and offal
        21
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM01AE91
Authorisation status:
  • Valid
Authorised in:
  • Slovenia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • GENERA SI podjetje za zastopanje in trgovino d.o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Genera d.d.
Responsible authority:
  • Agency For Medicinal Products And Medical Devices Of The Republic Of Slovenia
Authorisation number:
  • NP/V/0418/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 28/11/2021

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 28/11/2021
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."